Clinical Trials
12 trialsNCT06032728 2023-09-13
Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment
First Affiliated Hospital, Sun Yat-Sen University
Phase NA Not yet recruiting
NCT05816642 2023-04-18
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
RenJi Hospital
Phase NA Unknown
NCT03571438 2020-01-18
COMBOREIN
University Hospital, Grenoble
Phase NA Unknown
NCT00428220 2019-06-27
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Pfizer
Phase NA Completed
NCT01502228 2019-03-05
PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma
Indiana University
Phase NA Terminated
NCT01740154 2018-12-06
Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer
Case Comprehensive Cancer Center
Phase NA Terminated
NCT00537056 2017-06-14
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Stanford University
Phase NA Completed
NCT00943839 2016-11-10
Sunitinib Malate in Treating Patients With Kidney Cancer
Centre Antoine Lacassagne
Phase NA Completed
NCT02688491 2016-02-25
A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment
First Affiliated Hospital, Sun Yat-Sen University
Phase NA Not yet recruiting
NCT00531544 2016-01-05
A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248
King Faisal Specialist Hospital & Research Center
Phase NA Completed
NCT00849186 2015-02-06
Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer
Roswell Park Cancer Institute
Phase NA Completed
NCT02208128 2014-08-04
MORE
Heidelberg University
Phase NA Unknown